S&P 500 7,553.68 â–ŧ 56.10 (-0.74%) DOW 50,687.07 â–ŧ 620.72 (-1.21%) NASDAQ 26,853.98 â–ŧ 239.92 (-0.89%) US Markets Closed â€ĸ 02:59 AM ET

ALRTF

ALR Technologies SG Ltd.

Price Chart
Latest Quote

$0.02

+0.00 (+0.00%)
Current Price
Previous Close $0.02
Open $0.02
Day High $0.02
Day Low $0.02
Volume 10,000
Fetched: 2026-06-04T06:58:59
Stock Information
Shares Outstanding 645.47M
Total Debt $32.28M
Cash Equivalents $20K
Net Income $-22.06M
Sector Healthcare
Industry Medical Devices
Market Cap $11.42M
EPS (TTM) $-0.04
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$43.05M
Income$-22.06M
Book/sh$-0.07
Cash/sh$0.00
Financial Ratios
Quick Ratio0.00
Current Ratio0.00
Returns & Margins
ROA-2839.60%
Ownership
Insider Ownership60.26%
Insider & Institutional transactions data not available
Valuation Ratios
PEG1.48
P/B-0.27
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.02
SMA50$0.02
SMA200$0.01
RSI68.92
ATR0.0014
Shares Float242.21M
Volatility2.31
Rel Volume0.19
Performance History
Week+18.00%
Month+5.36%
Quarter+92.39%
6 Months+47.50%
YTD+10.62%
Year+26.43%
3 Years-50.83%
5 Years-67.52%
10 Years+941.18%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-03 $0.02 2,500
2026-06-02 $0.02 10,000
2026-06-01 $0.02 7,000
2026-05-29 $0.02 20,000
2026-05-28 $0.02 13,800
2026-05-27 $0.01 2,285
2026-05-26 $0.01 36,599
2026-05-22 $0.01 110
2026-05-21 $0.01 0
2026-05-20 $0.01 24,199
2026-05-19 $0.02 14,375
2026-05-18 $0.02 52,080
2026-05-15 $0.01 37,500
2026-05-14 $0.01 1,000
2026-05-13 $0.01 7,600
2026-05-12 $0.01 17,200
2026-05-11 $0.02 5,600
2026-05-08 $0.02 5,000
2026-05-07 $0.02 0
2026-05-06 $0.02 0
2026-05-05 $0.02 2,824
2026-05-04 $0.02 50,000
About ALR Technologies SG Ltd.

ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of diabetes solution product for use by veterinarians in animal health. In addition, it offers healthcare services, including medical clinics, hospitals, and health plans, and veterinary clinics with diabetics being the initial patient targets. The company sells its products directly and through distributors in the United States, Brazil, the United Kingdom, European Union, and internationally. The company was incorporated in 1987 and is based in Singapore.

📰 Latest News
No news articles available at the moment. Check back later for updates on ALRTF.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $0 $22,096 $1,176 $2,523
Cost Of Revenue $0 $22,096 $1,176 $2,523
Total Revenue $0 $25,536 $2,367 $7,468
Operating Revenue $0 $25,536 $2,367 $7,468
Expenses
Interest Expense $12,424,430 $2,521,543 $6,350,401 $5,468,328
Total Expenses $3,499,866 $4,800,404 $4,212,317 $2,913,519
Rent Expense Supplemental $19,000 $47,000 $44,000 $25,000
Other Income Expense $46,900 $-179,000 $-59,000 $-68,614
Net Non Operating Interest Income Expense $-12,424,430 $-2,521,543 $-6,350,401 $-5,468,328
Interest Expense Non Operating $12,424,430 $2,521,543 $6,350,401 $5,468,328
Operating Expense $3,499,866 $4,778,308 $4,211,141 $2,910,996
General And Administrative Expense $2,616,000 $3,374,000 $3,729,000 $2,412,000
Selling And Marketing Expense - - - $132,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-15,877,514 $-7,474,514 $-10,618,809 $-8,443,315
Net Interest Income $-12,424,430 $-2,521,543 $-6,350,401 $-5,468,328
Normalized Income $-15,924,414 $-7,295,514 $-10,559,809 $-8,374,701
Net Income From Continuing And Discontinued Operation $-15,877,514 $-7,474,514 $-10,618,809 $-8,443,315
Net Income Common Stockholders $-15,877,514 $-7,474,514 $-10,618,809 $-8,443,315
Net Income $-15,877,514 $-7,474,514 $-10,618,809 $-8,443,315
Net Income Including Noncontrolling Interests $-15,877,396 $-7,475,411 $-10,619,351 $-8,442,993
Net Income Continuous Operations $-15,877,396 $-7,475,411 $-10,619,351 $-8,442,993
Pretax Income $-15,877,396 $-7,475,411 $-10,619,351 $-8,442,993
Special Income Charges $-41,100 $-139,000 $0 $-33,614
Operating Income $-3,499,866 $-4,774,868 $-4,209,950 $-2,906,051
Gross Profit $0 $3,440 $1,191 $4,945
Total Operating Income As Reported - $-4,813,971 $-4,269,599 $-2,941,373
Per Share
Diluted EPS $-0.03 $-0.01 $-0.02 $-0.02
Basic EPS $-0.03 $-0.01 $-0.02 $-0.02
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-3,499,866 $-4,774,868 $-4,209,950 $-2,906,051
Total Unusual Items $46,900 $-179,000 $-59,000 $-68,614
Total Unusual Items Excluding Goodwill $46,900 $-179,000 $-59,000 $-68,614
EBITDA (Bullshit earnings) $-3,452,966 $-4,953,868 $-4,268,950 $-2,974,665
EBIT $-3,452,966 $-4,953,868 $-4,268,950 $-2,974,665
Diluted Average Shares $598,924,378 $581,016,295 $548,078,686 $534,980,347
Basic Average Shares $598,924,378 $581,016,295 $548,078,686 $534,980,347
Diluted NI Availto Com Stockholders $-15,877,514 $-7,474,514 $-10,618,809 $-8,443,315
Other Special Charges $41,100 $139,000 - $33,614
Write Off $41,100 $0 $0 -
Gain On Sale Of Security $88,000 $-40,000 $-59,000 $-35,000
Research And Development $883,866 $1,404,308 $482,141 $498,996
Selling General And Administration $2,616,000 $3,374,000 $3,729,000 $2,412,000
Other Gand A $375,000 $657,000 $1,114,000 $886,000
Rent And Landing Fees $19,000 $47,000 $44,000 $25,000
Salaries And Wages $2,222,000 $2,670,000 $2,571,000 $1,501,000
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-36,223,719 $-31,916,155 $-28,554,785 $-24,312,143
Total Assets $79,472 $155,198 $377,289 $193,217
Total Non Current Assets $0 $0 $0 $0
Current Assets $79,472 $155,198 $377,289 $193,217
Prepaid Assets $27,952 $44,016 $228,661 $77,295
Inventory $10,863 $11,000 $0 -
Receivables $0 $41,100 $0 -
Accounts Receivable $0 $41,100 $0 -
Cash Cash Equivalents And Short Term Investments $40,657 $59,082 $148,628 $115,922
Cash And Cash Equivalents $40,657 $59,082 $148,628 $115,922
Cash Financial $40,657 $59,082 $148,628 $115,922
Debt
Net Debt $28,581,882 $25,340,800 $22,777,843 $19,148,245
Total Debt $28,622,539 $25,399,882 $22,926,471 $19,264,167
Current Debt And Capital Lease Obligation $28,622,539 $25,399,882 $21,083,489 $17,321,711
Current Debt $28,622,539 $25,399,882 $21,083,489 $17,321,711
Other Current Borrowings $22,550,625 $20,415,460 $15,828,155 $14,279,745
Long Term Debt And Capital Lease Obligation - - $1,842,982 $1,942,456
Long Term Debt - - $1,842,982 $1,942,456
Liabilities
Total Liabilities Net Minority Interest $36,303,191 $32,071,353 $28,932,074 $24,505,360
Total Non Current Liabilities Net Minority Interest $0 $0 $1,842,982 $1,942,456
Current Liabilities $36,303,191 $32,071,353 $27,089,092 $22,562,904
Current Notes Payable $6,071,914 $4,984,422 $5,255,334 $3,041,966
Payables And Accrued Expenses $7,680,652 $6,671,471 $6,005,603 $5,238,793
Interest Payable $5,701,679 $5,170,149 $4,662,731 $4,110,647
Payables $1,678,839 $1,183,037 $1,054,285 $806,059
Accounts Payable $1,678,839 $1,183,037 $1,054,285 $806,059
Current Deferred Liabilities - $2,905 $0 $2,400
Equity
Common Stock Equity $-36,223,719 $-31,916,155 $-28,554,785 $-24,312,143
Total Equity Gross Minority Interest $-36,223,719 $-31,916,155 $-28,554,785 $-24,312,143
Stockholders Equity $-36,223,719 $-31,916,155 $-28,554,785 $-24,312,143
Gains Losses Not Affecting Retained Earnings $-844 $-844 $6,147 $-11,409
Retained Earnings $-135,985,914 $-120,108,400 $-112,633,886 $-102,015,077
Other
Ordinary Shares Number $635,466,844 $632,466,844 $551,966,844 $542,716,344
Share Issued $635,466,844 $632,466,844 $551,966,844 $542,716,344
Tangible Book Value $-36,223,719 $-31,916,155 $-28,554,785 $-24,312,143
Invested Capital $-7,601,180 $-6,516,273 $-5,628,314 $-5,047,976
Working Capital $-36,223,719 $-31,916,155 $-26,711,803 $-22,369,687
Total Capitalization $-36,223,719 $-31,916,155 $-26,711,803 $-22,369,687
Foreign Currency Translation Adjustments $-844 $-844 $6,147 $-11,409
Additional Paid In Capital $68,477,402 $57,280,320 $56,032,129 $50,043,543
Capital Stock $31,285,637 $30,912,769 $28,040,825 $27,670,800
Common Stock $31,285,637 $30,912,769 $28,040,825 $27,670,800
Current Accrued Expenses $6,001,813 $5,488,434 $4,951,318 $4,432,734
Treasury Shares Number - $0 - -
Current Deferred Revenue - $2,905 $0 $2,400
Preferred Stock - - $0 $0
Line Of Credit - - - $14,008,833
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-1,539,756 $-1,621,664 $-2,573,606 $-2,224,970
Operating Activities
Operating Cash Flow $-1,539,756 $-1,621,664 $-2,573,606 $-2,224,970
Cash Flow From Continuing Operating Activities $-1,539,756 $-1,621,664 $-2,573,606 $-2,224,970
Operating Gains Losses $-74,458 $174,827 - $33,614
Financing Activities
Issuance Of Capital Stock $0 $744,655 $25 $1,136,832
Financing Cash Flow $1,521,331 $1,539,109 $2,507,261 $2,286,111
Cash Flow From Continuing Financing Activities $1,521,331 $1,539,109 $2,507,261 $2,286,111
Net Common Stock Issuance $0 $744,655 $25 $1,136,832
Common Stock Issuance $0 $744,655 $25 $1,136,832
Cash Dividends Paid - - $0 $0
Other
Repayment Of Debt $0 $0 $-649,708 $0
Issuance Of Debt $1,515,331 $794,454 $3,156,944 $1,149,279
End Cash Position $40,657 $59,082 $148,628 $115,922
Beginning Cash Position $59,082 $148,628 $115,922 $66,190
Effect Of Exchange Rate Changes $0 $-6,991 $99,051 $-11,409
Changes In Cash $-18,425 $-82,555 $-66,345 $61,141
Proceeds From Stock Option Exercised $6,000 $0 $0 -
Net Issuance Payments Of Debt $1,515,331 $794,454 $2,507,236 $1,149,279
Net Short Term Debt Issuance $1,515,331 $794,454 $727,986 $1,149,279
Short Term Debt Payments $0 $0 $-649,708 $0
Short Term Debt Issuance $1,515,331 $794,454 $1,377,694 $1,149,279
Net Long Term Debt Issuance $0 $0 $1,779,250 $0
Long Term Debt Issuance $0 $0 $1,779,250 $0
Interest Paid Cfo $-257,666 $-310,603 $-496,081 -
Change In Working Capital $1,025,382 $1,133,413 $728,794 $723,712
Change In Payables And Accrued Expense $1,009,181 $983,868 $880,160 $738,348
Change In Accrued Expense $531,530 $531,418 $542,834 $527,336
Change In Interest Payable $531,530 $531,418 $542,834 $527,336
Change In Payable $477,651 $452,450 $337,326 $211,012
Change In Account Payable $477,651 $452,450 $337,326 $211,012
Change In Prepaid Assets $16,064 $201,645 $-151,366 $-14,636
Change In Inventory $137 $-11,000 $0 $0
Change In Receivables $0 $-41,100 $0 $0
Changes In Account Receivables $0 $-41,100 $0 $0
Other Non Cash Items $2,071,960 $1,988,164 $2,042,310 $1,057,801
Stock Based Compensation $11,531,440 $2,867,049 $5,770,180 $4,403,218
Asset Impairment Charge $41,100 $0 $0 -
Net Foreign Currency Exchange Gain Loss $-74,458 $35,827 $0 $0
Net Income From Continuing Operations $-15,877,514 $-7,474,514 $-10,618,809 $-8,443,315
Interest Paid Cff - - $-496,081 $-456,725
Fetched: 2026-02-02